BILL · 2025–26 SESSION

SB 5204: Ibogaine-assisted therapy

Concerning ibogaine-assisted therapy.

Summary

  • Creates a three-year study at the University of Washington to determine the effectiveness of ibogaine-assisted therapy compared to treatment-as-usual for adults diagnosed with opioid use disorder.

From the Senate Bill Report (Orig.) (SB 5204), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 13, 2025
  2. Out of committeestopped here
  3. Passed Senate
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Jesse Salomon (D-32)
Introduced
January 13, 2025 in the Senate
Last action
January 12, 2026
Budget
Has a fiscal note

AN ACT Relating to studying outcomes of ibogaine-assisted therapy to treat adults with opioid use disorder;

Sponsors

Prime sponsor: Jesse Salomon (D-32)

2 co-sponsors (2 Democrats, 0 Republicans)

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. By resolution, reintroduced and retained in present status.
  2. First reading, referred to Health & Long-Term Care.
  3. Prefiled for introduction.

SB 5204 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page